Suppr超能文献

基质金属蛋白酶定量凝胶酶谱法的重新评估

Reappraisal of quantitative gel zymography for matrix metalloproteinases.

作者信息

Prescimone Tommaso, Tognotti Danika, Caselli Chiara, Cabiati Manuela, D'Amico Andrea, Del Ry Silvia, Giannessi Daniela

机构信息

Consiglio Nazionale delle Ricerche (CNR), Institute of Clinical Physiology, Laboratory of Cardiovascular Biochemistry, Pisa, Italy.

出版信息

J Clin Lab Anal. 2014 Sep;28(5):374-80. doi: 10.1002/jcla.21696. Epub 2014 Mar 19.

Abstract

BACKGROUND

The determination of matrix metalloproteases (MMPs) is relevant in many pathophysiological conditions, especially if associated with extracellular matrix remodeling; however, the results obtained are closely linked to the method used and are not directly comparable. The aim of this study was to perform a reappraisal of quantitative gel zymography technique for MMPs in human plasma, to use for comparison with commercially available ELISA and in those experimental conditions where the MMP active form needs to be revealed.

METHODS

The critical methodological parameters of zymography were checked and a comparison with a routinely used ELISA was performed.

RESULTS

Sensitivity and reproducibility levels of zymography are suitable for detection of MMP-9 in human plasma, providing results closely related to those obtained by ELISA.

CONCLUSIONS

Analytical parameters of zymography were suitable for detection of MMPs in human plasma. Quantitative zymography for MMPs is an alternative method for comparing the results of ELISA widely employed for MMP determination, thus reducing the discrepancies between laboratories regarding gelatinase assay.

摘要

背景

基质金属蛋白酶(MMPs)的测定在许多病理生理状况中具有重要意义,特别是当与细胞外基质重塑相关时;然而,所获得的结果与所使用的方法密切相关,且无法直接进行比较。本研究的目的是对用于检测人血浆中MMPs的定量凝胶酶谱技术进行重新评估,以便与市售酶联免疫吸附测定(ELISA)进行比较,并用于那些需要揭示MMP活性形式的实验条件。

方法

检查了酶谱法的关键方法学参数,并与常规使用的ELISA进行了比较。

结果

酶谱法的灵敏度和重现性水平适用于检测人血浆中的MMP-9,所提供的结果与ELISA法获得的结果密切相关。

结论

酶谱法的分析参数适用于检测人血浆中的MMPs。MMPs的定量酶谱法是一种替代方法,可用于比较广泛用于MMP测定的ELISA结果,从而减少实验室之间在明胶酶测定方面的差异。

相似文献

1
Reappraisal of quantitative gel zymography for matrix metalloproteinases.
J Clin Lab Anal. 2014 Sep;28(5):374-80. doi: 10.1002/jcla.21696. Epub 2014 Mar 19.
2
Zymography as a Research Tool in the Study of Matrix Metalloproteinase Inhibitors.
Methods Mol Biol. 2017;1626:79-102. doi: 10.1007/978-1-4939-7111-4_8.
3
4
Analysis of Enzymatic Activity of Matrix Metalloproteinase (MMP) by Collagen Zymography in Melanoma.
Methods Mol Biol. 2018;1731:97-106. doi: 10.1007/978-1-4939-7595-2_10.
5
Imbalanced circulating matrix metalloproteinases in polycystic ovary syndrome.
Mol Cell Biochem. 2011 Jul;353(1-2):251-7. doi: 10.1007/s11010-011-0793-6. Epub 2011 Mar 25.
6
Matrix metalloproteinases in blood from patients with LAM.
Respir Med. 2009 Jan;103(1):124-9. doi: 10.1016/j.rmed.2008.07.017. Epub 2008 Aug 29.
7
Assessment of Matrix Metalloproteinases by Gelatin Zymography.
Methods Mol Biol. 2016;1406:151-9. doi: 10.1007/978-1-4939-3444-7_12.
8
Matrix metalloproteinases and their tissue inhibitors in serum and cerebrospinal fluid of patients with amyotrophic lateral sclerosis.
Eur J Neurol. 2010 Feb;17(2):226-31. doi: 10.1111/j.1468-1331.2009.02775.x. Epub 2009 Oct 1.
10
Determination of matrix metalloproteinase activity using biotinylated gelatin.
Anal Biochem. 2000 Nov 1;286(1):149-55. doi: 10.1006/abio.2000.4798.

引用本文的文献

1
Clinical significance of matrix metalloproteinase-9 in Fragile X Syndrome.
Sci Rep. 2022 Sep 13;12(1):15386. doi: 10.1038/s41598-022-19476-y.
3
In Vitro Liver Toxicity Testing of Chemicals: A Pragmatic Approach.
Int J Mol Sci. 2021 May 10;22(9):5038. doi: 10.3390/ijms22095038.
4
Change in Proteolytic Profile in Heifers After Oligofructose Overload.
Front Vet Sci. 2020 Dec 18;7:580375. doi: 10.3389/fvets.2020.580375. eCollection 2020.

本文引用的文献

1
Circulating matrix metalloproteinases and tissue inhibitors of metalloproteinases in cardiac amyloidosis.
J Am Heart Assoc. 2013 Mar 12;2(2):e005868. doi: 10.1161/JAHA.112.005868.
3
Matrix metalloproteinases as drug targets in acute pulmonary embolism.
Curr Drug Targets. 2013 Mar;14(3):344-52. doi: 10.2174/1389450111314030006.
4
Matrix metalloproteinase-2 and -9 levels in patients with dilated ascending aorta and bicuspid aortic valve.
Echocardiography. 2013 Feb;30(2):121-6. doi: 10.1111/echo.12004. Epub 2012 Oct 24.
5
Novel biodegradable, biomimetic and functionalised polymer scaffolds to prevent expansion of post-infarct left ventricular remodelling.
J Mater Sci Mater Med. 2012 Jan;23(1):205-16. doi: 10.1007/s10856-011-4506-1. Epub 2011 Dec 6.
8
Matrix metalloproteinase inhibitor properties of tetracyclines: therapeutic potential in cardiovascular diseases.
Pharmacol Res. 2011 Dec;64(6):551-60. doi: 10.1016/j.phrs.2011.05.005. Epub 2011 May 31.
9
Matrix metalloproteinases: targets for doxycycline to prevent the vascular alterations of hypertension.
Pharmacol Res. 2011 Dec;64(6):567-72. doi: 10.1016/j.phrs.2011.04.002. Epub 2011 Apr 9.
10
Regulation of matrix metalloproteinase activity in health and disease.
FEBS J. 2011 Jan;278(1):28-45. doi: 10.1111/j.1742-4658.2010.07920.x. Epub 2010 Nov 19.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验